Back | Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
$HILS should we be shorting? | tw0122 | investorshub | 04/15/2023 6:46:52 AM |
great article | subslover | investorshub | 04/15/2023 6:39:26 AM |
When is this gonna take off? | harry crumb | investorshub | 04/15/2023 4:48:54 AM |
The now | subslover | investorshub | 04/14/2023 11:09:42 PM |
MomentumIts gaining last up | harry crumb | investorshub | 04/14/2023 10:34:52 PM |
$HILS what does this mean? | PennyPusher786 | investorshub | 04/14/2023 7:56:56 PM |
Price gaining | harry crumb | investorshub | 04/14/2023 7:23:28 PM |
MomentumIts now up | harry crumb | investorshub | 04/14/2023 5:17:17 PM |
$HILS best news of the day | tw0122 | investorshub | 04/14/2023 9:28:52 AM |
$HILS MomentumIts gaining last up | TheFinalCD | investorshub | 04/14/2023 5:27:19 AM |
$HILS Good read | harry crumb | investorshub | 04/14/2023 1:23:30 AM |
$HILS Thoughts on where this is headed? | harry crumb | investorshub | 04/13/2023 10:10:47 PM |
$HILS Price trading | Triple nickle | investorshub | 04/13/2023 9:45:57 PM |
nice dip here, i may get back in, | gail | investorshub | 04/13/2023 7:36:27 PM |
$HILS The gaining last trade up | subslover | investorshub | 04/13/2023 2:00:57 PM |
and there she goes! | gail | investorshub | 04/13/2023 1:32:29 PM |
$HILS Thoughts on where this is headed? | Triple nickle | investorshub | 04/13/2023 1:01:36 PM |
$HILS Do we have a winner?Turn around time? | harry crumb | investorshub | 04/13/2023 1:41:16 AM |
here we go bulls news is here | subslover | investorshub | 04/13/2023 12:02:19 AM |
going up on a/h trading, this board is | gail | investorshub | 04/12/2023 11:49:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...